From: Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
PD(n = 223) | HC (n = 169) | NDC (n = 68) | p value a | |
---|---|---|---|---|
Cohort 1 | ||||
Number of individuals | 36 | 43 | – | |
Age, mean ± SE | 64.4 ± 1.5 | 65.5 ± 1.2 | – | 0.6826 |
Gender (m/f) | 20/16 | 25/18 | – | 0.8173 |
Duration of disease (year), mean ± SE | 4.4 ± 0.8 | – | – | |
H&Y stage, mean ± SE | 2.1 ± 0.1 | – | – | |
Cohort 2 | ||||
Number of individuals | 65 | 32 | – | |
Age, mean ± SE | 66.2 ± 1.3 | 64.6 ± 1.7 | – | 0.6367 |
Gender (m/f) | 36/29 | 18/14 | – | 0.9651 |
Duration of disease (year), mean ± SE | 5.1 ± 0.5 | – | – | |
H&Y stage, mean ± SE | 2.1 ± 0.1 | – | – | |
Cohort 3 | ||||
Number of individuals | 122 | 94 | 68 | |
Age, mean ± SE | 68.2 ± 1.0 | 68.6 ± 0.8 | 68.6 ± 1.1 | 0.9576 |
Gender (m/f) | 68/54 | 51/43 | 37/31 | 0.9720 |
Duration of disease (year), mean ± SE | 5.6 ± 0.4 | – | – | |
H&Y stage, mean ± SE | 2.4 ± 0.1 | – | – |